RxDoctor Payments DataLook up a doctor →

Deetta Debault

Gerontology · Fort Myers, FLNPI 1477960888

Payments from drug & device makers

$14,328in general payments, 2019–2025

Across 758 payments — averaging $18.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • GSK$1K
  • Novo Nordisk$1K
  • AstraZeneca$990
  • Merck$829
  • Pfizer$578
  • plus $8K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)72$1,386
GSK66$1,183
Novo Nordisk55$1,006
AstraZeneca40$990
Merck35$829
Pfizer33$578
Novartis34$557
Amgen34$541
Lilly USA, LLC34$518
Bayer19$481
Axsome Therapeutics, Inc.19$465
Antares Pharma, Inc.23$440
Johnson & Johnson17$368
Sanofi-aventis U.S. LLC18$353
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)20$351
Amarin Pharma, Inc.18$309
Sunovion Pharmaceuticals Inc.14$280
Kowa Pharmaceuticals America, Inc.18$254
Sumitomo Pharma America, Inc.13$248
Biohaven Pharmaceutical Holding Company Ltd.14$235
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC11$189
Takeda Pharmaceuticals U.S.A., Inc.10$185
Astellas Pharma US Inc10$165
Lundbeck LLC8$157
Otsuka America Pharmaceutical, Inc.7$152
Esperion Therapeutics, Inc.8$132
Clarus Therapeutics Inc.8$123
Biohaven Pharmaceuticals, Inc.10$115
Boehringer Ingelheim7$111
Eisai Inc.5$106
Teva Pharmaceuticals USA, Inc.6$97
Optinose US, Inc.5$93
Radius Health, Inc.4$81
Regeneron Healthcare Solutions, Inc.3$79
Jazz Pharmaceuticals Inc.5$78
Dexcom, Inc.4$78
Idorsia Pharmaceuticals US Inc4$73
Cvrx, Inc.3$71
Xeris Pharmaceuticals, Inc.3$69
Phathom Pharmaceuticals, Inc.4$68
Exact Sciences2$56
Halozyme Inc3$52
Currax Pharmaceuticals LLC4$52
Alnylam Pharmaceuticals Inc.2$49
Azurity Pharmaceuticals, Inc.2$48
Avanir Pharmaceuticals, Inc.2$47
Abbott2$40
Amryt Pharma Holdings Ltd2$38
Daiichi Sankyo Inc.2$38
Corcept Therapeutics2$38
Almatica Pharma LLC2$30
Kyowa Kirin, Inc.1$29
Paratek Pharmaceuticals, Inc.2$29
E.r. Squibb & Sons, L.L.C.1$26
Scilex Pharmaceuticals Inc.1$25
Corium, LLC1$24
Grifols USA, LLC1$24
Stryker1$23
Chiesi USA, Inc.1$23
Medtronic1$15

How this compares

$14,328 in reported general payments places this provider in the 95th percentile of 714 gerontology providers in Florida.

See all gerontology providers in Florida

Medicare billing

Part B allowed, 2024
$130,070
Medicare patients
291
Services billed
4,414

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gerontology in Fort Myers

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →